Covered recipient · General Payments record
CHRISTINE HOSCHEIT
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2024
$780.32
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $499.98 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $157.02 | 7 |
| DEXCOM, INC. | $104.49 | 5 |
| Amgen Inc. | $67.96 | 4 |
| Averitas Pharma Inc. | $34.24 | 1 |
| Xeris Pharmaceuticals, Inc. | $33.88 | 2 |
| CHIESI USA, INC. | $23.57 | 1 |
| Novo Nordisk AS | $22.74 | 1 |
| Medtronic, Inc. | $22.36 | 1 |
| Ascensia Diabetes Care US Inc. | $18.68 | 1 |
| Neurocrine BioSciences, Inc. | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.18 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601676 | CMS |
| Amgen Inc. | $14.37 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601678 | CMS |
| Amgen Inc. | $13.96 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601680 | CMS |
| Amgen Inc. | $22.45 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601682 | CMS |
| Ascensia Diabetes Care Us Inc. | $18.68 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089090668 | CMS |
| Averitas Pharma Inc. | $34.24 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133430043 | CMS |
| Chiesi USA, Inc. | $23.57 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151808829 | CMS |
| Dexcom, Inc. | $21.61 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292009 | CMS |
| Dexcom, Inc. | $25.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292011 | CMS |
| Dexcom, Inc. | $16.70 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292013 | CMS |
| Dexcom, Inc. | $23.38 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292015 | CMS |
| Dexcom, Inc. | $17.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292017 | CMS |
| Lilly USA, LLC | $18.19 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136099520 | CMS |
| Lilly USA, LLC | $21.65 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136099522 | CMS |
| Lilly USA, LLC | $30.02 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136109942 | CMS |
| Lilly USA, LLC | $23.69 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136102082 | CMS |
| Lilly USA, LLC | $28.58 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136095901 | CMS |
| Lilly USA, LLC | $19.89 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136109940 | CMS |
| Lilly USA, LLC | $15.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136120696 | CMS |
| Medtronic, Inc. | $22.36 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119387402 | CMS |
| Neurocrine Biosciences, Inc. | $15.04 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150875068 | CMS |
| Novo Nordisk Inc | $22.74 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097386436 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.74 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590456 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.14 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590458 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.